Effect of Hydroquinone on Skin Discomfort

Prospective, randomized, double-blind clinical study of split-body comparison of topical hydroquinone and hexylresorcinol for skin pigment appearance (2023)

A Multi-Center, Randomized, Blinded Clinical Study Evaluating the Efficacy and Safety of a Novel Topical Product for Facial Dyschromia (2023)

A Randomized, Double-Blind, Split-Face Study of Topical Silymarin vs 2% Hydroquinone Cream in Melasmas (2022)

Efficacy and safety of topical isobutylamido thiazolyl resorcinol (Thiamidol) vs. 4% hydroquinone cream for facial melasma: an evaluator-blinded, randomized controlled trial (2021)

Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial (2021)

A comparative study of topical 5% cysteamine versus 4% hydroquinone in the treatment of facial melasma in women (2020)

Effective Tyrosinase Inhibition by Thiamidol Results in Significant Improvement of Mild to Moderate Melasma (2019)

Topical silymarin versus hydroquinone in the treatment of melasma: A comparative study (2019)

A Comparative Study of the Efficacy of 4% Hydroquinone vs 0.75% Kojic Acid Cream in the Treatment of Facial Melasma (2013)

Clinical efficacy and safety of a multimodality skin brightener composition compared with 4% hydroquinone (2012)

A randomized controlled trial of the efficacy and safety of a fixed triple combination (fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%) compared with hydroquinone 4% cream in Asian patients with moderate to severe melasma (2008)

A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma (2007)

The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream (1991)

Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma (1989)